Trevor Brown Joins DCN Dx as Chief Revenue Officer

Brown assumes responsibility for the company’s global commercial strategy, overseeing sales, marketing, and client expansion across its three core divisions: assay development and manufacturing, regulatory and clinical trial support, and biospecimen sourcing. His mandate includes steering the organization through its next phase of growth by leveraging these integrated services to assist partners in accelerating product development.

Prior to joining DCN Dx, Brown held senior leadership positions at companies including Luminex, BD, and SeraCare Life Sciences, where he managed the launch of multiple FDA- and CE-cleared diagnostic products. According to CEO Charlie Mamrak, Brown’s expertise in the full commercialization pathway aligns with the company's goal of reducing development costs and de-risking the journey for diagnostic startups and established manufacturers alike.